Search
for

    GlossaryBisphosphonates

    drugs that prevent bone density loss by inhibiting osteoclasts

    Bisphosphonates, also known as diphosphonates, are a class of drugs that prevent the loss of bone density. They are commonly prescribed to treat osteoporosis and similar bone diseases by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This helps to strengthen bones and reduce the risk of fractures.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 155 results
      Gonadal Dysgenesis and Bone Metabolism

      research Gonadal Dysgenesis and Bone Metabolism

      45 citations , February 2001 in “Joint bone spine”
      Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.
      Menopause

      research Menopause

      3 citations , January 2007 in “Elsevier eBooks”
      The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.
      Wound Healing, Cutaneous Therapy, Hair

      research Wound Healing, Cutaneous Therapy, Hair

      April 2008 in “Medical & surgical dermatology”
      Certain hairstyles can cause scalp diseases, smoking is linked to hair loss, 5% minoxidil foam is effective for hair loss treatment, and various factors influence wound healing and hair growth.
      Foreword

      research Foreword

      June 2007 in “Endocrinology and Metabolism Clinics of North America”
      The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.
    View more "bisphosphonates" in research →

    Community Join

    0 / 0 results
    — no results